Joseph D. Abad

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

Daniel S. Pereira, Claudia Guevara, Liqing Jin et al. · Molecular Cancer Therapeutics · 2015 · 93 citations · Full text

Immunology, Immunotherapeutics, Immunotherapy +18

Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i> , a New Urothelial Cancer Biomarker

Kendall Morrison, Pia M. Challita-Eid, Arthur Raitano et al. · Molecular Cancer Therapeutics · 2016 · 65 citations · Full text

Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists

Nissar A. Darmani, Yaozhi Wang, Joseph D. Abad et al. · Brain Research · 2008 · 57 citations · Full text

Medicinal Chemistry, Functional Selectivity, Pharmacology +9

A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: Evidence from the least shrew

Nissar A. Darmani, Jennifer L. Crim, Jano J. Janoyan et al. · Brain Research · 2008 · 51 citations

Psychotropic Medication, Pharmacology, Gastroenterology +8

New tissue microarray technology for analyses of gene expression in frozen pathological samples

Lei Zhou, Melissa Hodeib, Joseph D. Abad et al. · BioTechniques · 2007 · 18 citations · Full text